A Comparative Study among the Essential Medicine List, National Insurance Medicine List of China, and National Essential Medicine List of the WHO_Chinese Journal of Evidence-Based Medicine

Authors：

1. West China School of Pharmacy, Sichuan University,Chengdu 610041, China;2. The Chinese Cochrane Centre / Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China;3. West China School of Clinical Medicine, Sichuan University, Chengdu 610041, China;4. Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, China;

Corresponding author：

Keywords：

Essential medicines; Essential medicines list; Essential insurance medicines list; Selection; Updating

DOI：

10.7507/1672-2531.20090134

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective 　To compare the national essential medicines list (EML) and national essential insurance medicine list (EIML) of China with that of the WHO, so as to provide reasonable evidence for the adjustment of new EML and EIML of China.
Methods 　The similarities and differences in the selection, updating, categories, subcategories and the amounts of medicines in the EML and EIML of China and the WHO EML were compared and analyzed.
Results 　There are some differences among the three lists in selecting principles, updating of medicines .The latest version of WHO EML (version in 2007) has 27 categories, including 340 medicines; China EML (version in 2004) has 23 categories and 773 western medicines, containing 23 categories and 225 (66.17%) similar medicines of WHO EML, which accounts for 29.11% of EML of China. China EIML (version in 2005) has 23 categories and 1 031 western medicines, containing 22 categories and 227 (66.76%) of WHO EML, which accounts for 22.02% of EIML of China. China EIML was developed based on China EML. There is little difference in selecting, updating, categories of medicines.
Conclusion 　The difference was obviously found in medicine selection, updating and categories between China EML, EIML and WHO EML. We suggested that our national EML and EIML should be more reasonably selected and updated base on the principals of WHO EML.

Citation： ZHANG Chuan,WANG Li,YUAN Qiang,LI Youping,ZHANG Lingli. A Comparative Study among the Essential Medicine List, National Insurance Medicine List of China, and National Essential Medicine List of the WHO. Chinese Journal of Evidence-Based Medicine, 2009, 09(7): 765-773. doi: 10.7507/1672-2531.20090134 Copy

1.	Xavier S. A human rights approach to the WHO model list 0f essential medicines. Bul World Heal Orga, 2006, 84(5): 405.
2.	张震巍, 沈爱宗. 国家《基本医疗保险用药目录》与《基本药物目录》之比较分析. 中国卫生事业管理, 2004, 5: 317-318.
3.	关于规范国家基本医疗保险和工伤保险药品目录部分药品名称剂型等问题的通知. 劳社厅函[2007]162号, 2007, 5, 18.
4.	苗苗. 试点暴露基本药物制不完善需目录更新制度. 医院领导决策参考, 2008, (8): 36-38.
5.	肖宏浩, 郭振华, 饶晓兵. 澳大利亚的经验对我国基本药物目录遴选的启示. 中国药事, 2008, 22(11).
6.	世界卫生组织基本药物标准清单第15版. http://www.who.int/en/ 2009-04-04.
7.	国家基本药物（2004）[EB/OL] http://law.pharmanet.com.cn/ 2009-04-04.
8.	国家基本医疗保险和工伤保险药品目录. http://www.molss.gov.cn/gb/zt/ypml/ypml.htm2009-04-04.
9.	WHO《基本药物示范目录》品种数目历年变化情况怎样？http://www.sfda.gov.cn/WS01/CL0446/28060.html.2009-6-23.
10.	徐军. 医改的国际借鉴之一——基本药物制度. http://www.hxqh.com/bbs/UpFile/UpAttachment/2009-5/2009519135214. 2009-6-23.
11.	劳动和社会保障部发布《国家基本医疗保险和工伤保险药品目录（2004年版）》http://www.gxjy.cn/pub/html/2007/7/438.htm2009-6-23.
12.	WHO: WHO Medicines Strategy：Revised Procedure for Updating WHOs Model List of Essential Drugs. 7 December, 2001.
13.	SP Kishore1 and BJ Herbstman1 Adding a Medicine to the WHO Model List of Essential Medicines. Clinical Pharmacology & Therapeutics, 2009, 85(3): 237-239.
14.	扩大国家免疫实施方案. http://www.chinacdc.net.cn/n272442/n272530/n272742/22210.html.2009-06-08.
15.	Phil Wiffen. Evidence and essential medicines: the selection, evaluation and continuation of a medicines list. Chinese Journal of Evidence-Based Medicine, 2003, 3(2): 83-86.
16.	闫娟娟, 高文远, 张丽莉, 等. 基于层次分析法的国家基本药物遴选. 药事管理, 2009, 29 (2): a132-134.
17.	李易平. 国家基本药物目录与药物经济学的相关问题分析. 中国执业药师, 2009, 9(2): 30-32.
18.	陈永法, 邵蓉. 在实践中不断完善国家基本药物政策. 中国药业, 2005, 14(3): 21.
19.	申山. 全国政协委员会周超凡建议: 改革医保用药目录建立国家基本医疗制度. 中国医药指南, 2007, 3: 12.
20.	周帮旻, 王莉, 李幼平, 等. 成都市三圈7个乡镇和社区卫生服务机构药品使用现况调查--三圈七院六站预调查报告之三. 中国循证医学杂志, 2008, 8(7): 529-537.
21.	曾雁冰, 杨世民. 对基本药物认知及临床应用情况的调查研究. 中国药事, 2008, 22(9): 756-7630.
22.	计划生育统计公报(2001年5月): 跨省流动人口婚姻、生育、避孕情况. http://www.chinapop.gov.cn/fzgh/tjgz/200806/t20080626_154472.htm.2009-06-08.
23.	我国已婚育龄妇女避孕方法以长效为主(2001年2号)[EB/OL].http://www.chinapop.gov.cn/fzgh/tjgz/200804/t20080429_42973.htm. 2009-06-08.
24.	计划生育药具工作管理办法. [EB/OL] http://www.chinapop.gov.cn/wxzl/zywx/200805/t20080501_47925.htm 2009-6-9.
25.	李勇. 忽视苯妥英钠片剂规格变化引起的药物中毒. 中国社区医师, 2007, 23(10): 18-20.

1. Xavier S. A human rights approach to the WHO model list 0f essential medicines. Bul World Heal Orga, 2006, 84(5): 405.
2. 张震巍, 沈爱宗. 国家《基本医疗保险用药目录》与《基本药物目录》之比较分析. 中国卫生事业管理, 2004, 5: 317-318.
3. 关于规范国家基本医疗保险和工伤保险药品目录部分药品名称剂型等问题的通知. 劳社厅函[2007]162号, 2007, 5, 18.
4. 苗苗. 试点暴露基本药物制不完善需目录更新制度. 医院领导决策参考, 2008, (8): 36-38.
5. 肖宏浩, 郭振华, 饶晓兵. 澳大利亚的经验对我国基本药物目录遴选的启示. 中国药事, 2008, 22(11).
6. 世界卫生组织基本药物标准清单第15版. http://www.who.int/en/ 2009-04-04.
7. 国家基本药物（2004）[EB/OL] http://law.pharmanet.com.cn/ 2009-04-04.
8. 国家基本医疗保险和工伤保险药品目录. http://www.molss.gov.cn/gb/zt/ypml/ypml.htm2009-04-04.
9. WHO《基本药物示范目录》品种数目历年变化情况怎样？http://www.sfda.gov.cn/WS01/CL0446/28060.html.2009-6-23.
10. 徐军. 医改的国际借鉴之一——基本药物制度. http://www.hxqh.com/bbs/UpFile/UpAttachment/2009-5/2009519135214. 2009-6-23.
11. 劳动和社会保障部发布《国家基本医疗保险和工伤保险药品目录（2004年版）》http://www.gxjy.cn/pub/html/2007/7/438.htm2009-6-23.
12. WHO: WHO Medicines Strategy：Revised Procedure for Updating WHOs Model List of Essential Drugs. 7 December, 2001.
13. SP Kishore1 and BJ Herbstman1 Adding a Medicine to the WHO Model List of Essential Medicines. Clinical Pharmacology & Therapeutics, 2009, 85(3): 237-239.
14. 扩大国家免疫实施方案. http://www.chinacdc.net.cn/n272442/n272530/n272742/22210.html.2009-06-08.
15. Phil Wiffen. Evidence and essential medicines: the selection, evaluation and continuation of a medicines list. Chinese Journal of Evidence-Based Medicine, 2003, 3(2): 83-86.
16. 闫娟娟, 高文远, 张丽莉, 等. 基于层次分析法的国家基本药物遴选. 药事管理, 2009, 29 (2): a132-134.
17. 李易平. 国家基本药物目录与药物经济学的相关问题分析. 中国执业药师, 2009, 9(2): 30-32.
18. 陈永法, 邵蓉. 在实践中不断完善国家基本药物政策. 中国药业, 2005, 14(3): 21.
19. 申山. 全国政协委员会周超凡建议: 改革医保用药目录建立国家基本医疗制度. 中国医药指南, 2007, 3: 12.
20. 周帮旻, 王莉, 李幼平, 等. 成都市三圈7个乡镇和社区卫生服务机构药品使用现况调查--三圈七院六站预调查报告之三. 中国循证医学杂志, 2008, 8(7): 529-537.
21. 曾雁冰, 杨世民. 对基本药物认知及临床应用情况的调查研究. 中国药事, 2008, 22(9): 756-7630.
22. 计划生育统计公报(2001年5月): 跨省流动人口婚姻、生育、避孕情况. http://www.chinapop.gov.cn/fzgh/tjgz/200806/t20080626_154472.htm.2009-06-08.
23. 我国已婚育龄妇女避孕方法以长效为主(2001年2号)[EB/OL].http://www.chinapop.gov.cn/fzgh/tjgz/200804/t20080429_42973.htm. 2009-06-08.
24. 计划生育药具工作管理办法. [EB/OL] http://www.chinapop.gov.cn/wxzl/zywx/200805/t20080501_47925.htm 2009-6-9.
25. 李勇. 忽视苯妥英钠片剂规格变化引起的药物中毒. 中国社区医师, 2007, 23(10): 18-20.

Previous Article
Evidence-Based Evaluation of National Essential Medicine Lists in Twenty-five Countries
Next Article
Intensive Glucose Control Compared with Standard Therapy in Type 2 Diabetes: A Systemic Review

Chinese Journal of Evidence-Based Medicine

A Comparative Study among the Essential Medicine List, National Insurance Medicine List of China, and National Essential Medicine List of the WHO

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content